Baird Medical Appoints Mark Saxton as U.S. CEO to Drive Commercial Expansion
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) has announced the appointment of Mark Saxton as the Chief Executive Officer of its U.S. subsidiary. This strategic move is aimed at accelerating Baird Medical's entry into the U.S. market, leveraging Saxton's extensive experience in the medical device industry.
Profile of Mark Saxton and His Vision
Mark Saxton brings over 25 years of commercial leadership experience to Baird Medical, particularly in the realm of intravascular RF ablation technologies. In his new role, he will oversee all U.S. operations, including sales, marketing, and market development.
Haimei Wu, Chairwoman of Baird Medical, expressed enthusiasm about Saxton's appointment, stating, "His proven track record of taking novel technologies to market leadership...makes him the ideal leader for this critical phase of our growth."
In Saxton’s own words, "I am honored to join Baird Medical at this pivotal moment...I look forward to advancing our U.S. commercial strategy and expanding access for patients while building lasting value for shareholders."
Saxton’s Proven Track Record in Medtech
Mr. Saxton’s successful career includes scaling high-growth medtech companies, resulting in significant strategic exits:
- At VNUS Medical Technologies, he managed the U.S. commercialization of first-to-market intravascular RF ablation devices, which saw annual revenue double from $49 million to over $100 million in just over two years, leading to the company's acquisition by Covidien for $512 million.
- His leadership at NeuroPace contributed to a successful $117 million IPO.
- At Ceterix Orthopaedics, Saxton played a crucial role in repositioning the business for a $105 million acquisition by Smith + Nephew.
About Baird Medical
Baird Medical focuses on minimally invasive diagnostics and treatment solutions. The company aims to enhance patient outcomes with innovative surgical robotic systems and advanced surgical instruments. Baird Medical’s mission includes fostering strategic collaborations with leading academic institutions.
Recognized as an FDA 510(k)-certified medical device company, Baird Medical's solutions are currently used in over 30 prestigious hospitals and clinics across the United States, including notable institutions like the Mayo Clinic and UCSF Medical Center. Additionally, the company is a market leader in China for thyroid microwave ablation devices and consumables, with an expanding presence in over 20 countries worldwide.
Forward-Looking Statements
This announcement includes forward-looking statements regarding Baird Medical's future financial performance and operational prospects. Such statements may include terms like "may," "expect," "anticipate," and similar terminology. However, actual results can significantly differ due to various risks and uncertainties.
Baird Medical advises stakeholders not to rely excessively on these forward-looking statements, which are subject to change based on factors such as economic conditions, regulatory developments, and market competition.
Contact Information
For further inquiries, please contact:
Eric Huang
PR Liaison, Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: contact@bairdmedical.com